Studies have demonstrated that NUB1 overexpression can inhibit the growth of a wide range of tumors, including renal cell carcinoma, osteosarcoma, and gastric cancer, by inhibiting NEDD8 and its conjugation system [13–15]. This evidence concerns the gene NUB1 and osteosarcoma.